United States · Funded startup
4 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$83Mraised across 4 rounds since 2004, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by fiercebiotech.comSEC filing: $2.0M sold, first sale Aug 2010
No investor was named in the report.
From a historical funding recordSEC filing: $357K sold, first sale Oct 2009
Reported by investors.aryx.com
OrbiMed
MPM Capital
Montreux Growth Partners
ATEL Ventures
FLAG Capital Management, LLC
JAFCO Group
Itochu InternationalFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
ARYx Therapeutics's investors include OrbiMed, MPM Capital, New Enterprise Associates, Montreux Growth Partners and Lighthouse Capital Partners, and 7 more on record.
ARYx Therapeutics has raised $83M across 4 rounds since 2004.
ARYx Therapeutics's most recent round was a Debt of $6.3M in Aug 2010.
ARYx Therapeutics's largest round on record is $55M (Series D), in Jun 2004.
ARYx Therapeutics's first round on record, in Jun 2004, was backed by OrbiMed, MPM Capital and Montreux Growth Partners and 7 others.
ARYx Therapeutics's latest named round is a Debt, in Aug 2010.
ARYx Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 